Broadfin Capital as of Sept. 30, 2012
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 40 positions in its portfolio as reported in the September 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Santarus | 11.4 | $41M | 4.6M | 8.88 | |
Alkermes (ALKS) | 9.3 | $33M | 1.6M | 20.75 | |
Teva Pharmaceutical Industries (TEVA) | 8.9 | $32M | 764k | 41.41 | |
AngioDynamics (ANGO) | 6.5 | $23M | 1.9M | 12.20 | |
Natus Medical | 6.2 | $22M | 1.7M | 13.07 | |
Novadaq Technologies | 4.9 | $18M | 1.7M | 10.37 | |
Merit Medical Systems (MMSI) | 4.5 | $16M | 1.1M | 14.93 | |
Hi-Tech Pharmacal | 4.5 | $16M | 480k | 33.11 | |
MAKO Surgical | 3.9 | $14M | 806k | 17.41 | |
Lannett Company | 3.3 | $12M | 2.5M | 4.83 | |
Alere | 3.1 | $11M | 566k | 19.49 | |
Solta Medical | 3.0 | $11M | 3.5M | 3.14 | |
Impax Laboratories | 2.9 | $10M | 401k | 25.96 | |
Abiomed | 2.9 | $10M | 495k | 20.99 | |
DepoMed | 2.1 | $7.6M | 1.3M | 5.91 | |
St. Jude Medical | 2.1 | $7.4M | 176k | 42.13 | |
Emergent BioSolutions (EBS) | 2.0 | $7.1M | 500k | 14.21 | |
Anacor Pharmaceuticals In | 1.8 | $6.4M | 973k | 6.58 | |
Trius Therapeutics | 1.7 | $6.2M | 1.1M | 5.83 | |
Qlt | 1.7 | $6.1M | 785k | 7.79 | |
Flamel Technologies | 1.5 | $5.3M | 1.3M | 4.09 | |
Intellipharmaceuticsintl Inc C | 1.4 | $5.0M | 1.7M | 2.92 | |
AtriCure (ATRC) | 1.4 | $4.8M | 650k | 7.44 | |
Rigel Pharmaceuticals | 1.1 | $3.9M | 376k | 10.24 | |
NxStage Medical | 1.0 | $3.7M | 277k | 13.21 | |
ArthroCare Corporation | 1.0 | $3.6M | 110k | 32.40 | |
Masimo Corporation (MASI) | 0.9 | $3.4M | 141k | 24.18 | |
BioMimetic Therapeutics | 0.8 | $2.9M | 702k | 4.11 | |
Given Imaging | 0.7 | $2.6M | 179k | 14.57 | |
Rockwell Medical Technologies | 0.7 | $2.6M | 313k | 8.17 | |
Boston Scientific Corporation (BSX) | 0.6 | $2.2M | 391k | 5.74 | |
Conceptus | 0.6 | $2.0M | 99k | 20.31 | |
Derma Sciences | 0.4 | $1.6M | 150k | 10.38 | |
Cardionet | 0.2 | $697k | 277k | 2.52 | |
Nordion | 0.2 | $675k | 100k | 6.75 | |
MAP Pharmaceuticals | 0.2 | $643k | 41k | 15.56 | |
Zeltiq Aesthetics | 0.2 | $572k | 102k | 5.64 | |
CAS Medical Systems | 0.1 | $408k | 233k | 1.75 | |
Transcept Pharmaceuticals | 0.1 | $244k | 46k | 5.32 | |
Alphatec Holdings | 0.1 | $165k | 100k | 1.65 |